{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:37:28Z","timestamp":1790915848965,"version":"4.1.0"},"reference-count":68,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2008,11,18]],"date-time":"2008-11-18T00:00:00Z","timestamp":1226966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bipolar Disorders"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:p><jats:bold>Objectives:\u2002<\/jats:bold>Attenuation of protein kinase C (PKC) is a mechanism common to both established (lithium, valproate) and some novel (tamoxifen) antimanic agents. Verapamil, although primarily known as a calcium channel blocker, also has PKC inhibitory activity. Verapamil has shown antimanic activity in some but not all studies. Therefore, we investigated verapamil, used alone or as an adjunctive treatment, in manic patients who did not respond to an initial adequate trial of lithium.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold>Each study phase lasted three weeks. Subjects were treated openly with lithium in Phase 1 (n\u2003=\u200345). Those who failed to respond were randomly assigned to double\u2010blind treatment in Phase 2 with either verapamil (n\u2003=\u200310) or continued\u2010lithium (n\u2003=\u20038). Phase 2 nonresponders (n\u2003=\u200310) were assigned to combined verapamil\/lithium in Phase 3.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold>Response in Phase 2 did not differ significantly between verapamil and continued\u2010lithium. During Phase 3, response to combined treatment was significantly better than overall response to monotherapy in Phase 2 (Fisher\u2019s Exact test, p\u2003=\u20030.043). Mania ratings improved during combined treatment in Phase 3 by 88.2% (linear mixed model analysis,<jats:italic>F\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>4.34, p\u2003=\u20030.013), compared with 10.5% improvement during Phase 2.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold>In this preliminary investigation, verapamil monotherapy did not demonstrate antimanic efficacy. By contrast, the combination of verapamil plus lithium was highly efficacious. Our findings thus suggest that verapamil may have potential utility as an adjunct to lithium. This effect may be mediated by additive actions on PKC inhibition, which may be an important mechanism for antimanic agents in general.<\/jats:p>","DOI":"10.1111\/j.1399-5618.2008.00636.x","type":"journal-article","created":{"date-parts":[[2008,11,18]],"date-time":"2008-11-18T18:03:50Z","timestamp":1227031430000},"page":"856-866","source":"Crossref","is-referenced-by-count":38,"title":["Verapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: preliminary findings and a discussion of therapeutic mechanisms"],"prefix":"10.1111","volume":"10","author":[{"given":"Alan G","family":"Mallinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E","family":"Thase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Haskett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Buttenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Luckenbaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Kupfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husseini K","family":"Manji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,11,18]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2000.020204.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(00)00177-4"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2000.020403.x"},{"key":"e_1_2_6_5_2","first-page":"757","article-title":"Bipolar affective disorders and the role of intraneuronal calcium. Therapeutic effects of the treatment with lithium salts and\/or calcium antagonist in patients with rapid polar inversion","volume":"82","author":"Manna V","year":"1991","journal-title":"Minerva Med"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-001-0038-6"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(01)01338-5"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2002.125279"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1781(99)00116-X"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810070058010"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(91)90595-H"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.8"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1998.0491"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1100021"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.11.004"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000106054"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1993.tb07474.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1994.63062361.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1995.03950190013003"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.1.95"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2005.11.001"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2007.00530.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4002012"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.9.996"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-196901000-00010"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1979.tb04484.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.23.1.56"},{"key":"e_1_2_6_28_2","first-page":"17","article-title":"Clinical significance of reversed vegetative subtypes of recurrent major depression","volume":"27","author":"Thase ME","year":"1991","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_6_29_2","first-page":"217","volume-title":"ECDEU Assessment Manual for Psychopharmacology: DHEW Publication No. (ADM) 76\u2010338","author":"Guy W","year":"1976"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1987.tb01353.x"},{"key":"e_1_2_6_31_2","first-page":"454","article-title":"Choreoathetosis induced by verapamil and lithium treatment","volume":"9","author":"Helmuth D","year":"1989","journal-title":"J Clin Psychopharmacol"},{"key":"e_1_2_6_32_2","first-page":"371","article-title":"Verapamil: a new antimanic drug with potential interactions with lithium [see comment]","volume":"48","author":"Dubovsky S","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1986.tb02980.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(91)90035-K"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/hup.470100304"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(98)00308-4"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.149.1.118"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.154.7.976"},{"key":"e_1_2_6_39_2","first-page":"79S","article-title":"Hyperactive intracellular calcium mobilization in beta lymphoblasts from patients with bipolar 1 disorder","volume":"53","author":"Wasserman MJ","year":"2003","journal-title":"Biol Psychiatry"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)70391-3"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1981.tb10819.x"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2060587"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0968-0004(82)90177-3"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/331388a0"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/331440a0"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300400"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199810000-00009"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-0674(97)80058-0"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(99)00235-8"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(98)00627-7"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2000.20303.x"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(92)90598-4"},{"issue":"9","key":"e_1_2_6_53_2","first-page":"5","article-title":"Overview of the mechanism of action of lithium in the brain: fifty\u2010year update","volume":"61","author":"Lenox RH","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-000-0006-6"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(00)00929-X"},{"key":"e_1_2_6_56_2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0022-3565(24)37400-2","article-title":"Sodium valproate down\u2010regulates the myristoylated alanine\u2010rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C\u2010mediated mood stabilizers","volume":"285","author":"Watson DG","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_57_2","first-page":"129","volume-title":"Bipolar Medications: Mechanisms of Action","author":"Manji H","year":"2000"},{"key":"e_1_2_6_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.10.021"},{"key":"e_1_2_6_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(99)00828-6"},{"key":"e_1_2_6_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(92)90049-U"},{"key":"e_1_2_6_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(92)90048-T"},{"key":"e_1_2_6_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/0169-328X(93)90055-T"},{"key":"e_1_2_6_63_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2396(199707)26:3<281::AID-SYN9>3.0.CO;2-3"},{"key":"e_1_2_6_64_2","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0022-3565(24)37164-2","article-title":"Enhanced dopamine release and phosphorylation of synapsin I and neuromodulin in striatal synaptosomes after repeated amphetamine","volume":"283","author":"Iwata SI","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(93)90006-Y"},{"key":"e_1_2_6_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(95)00611-7"},{"key":"e_1_2_6_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(01)01147-7"},{"key":"e_1_2_6_68_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.17.11447"},{"key":"e_1_2_6_69_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature05911"}],"container-title":["Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-5618.2008.00636.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-5618.2008.00636.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T20:59:53Z","timestamp":1738529993000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-5618.2008.00636.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,18]]},"references-count":68,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["10.1111\/j.1399-5618.2008.00636.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-5618.2008.00636.x","archive":["Portico"],"relation":{},"ISSN":["1398-5647","1399-5618"],"issn-type":[{"value":"1398-5647","type":"print"},{"value":"1399-5618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,18]]}}}